Plant · Scientific monograph
Ilex paraguariensis
Yerba mate
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Metabolic research, Dietary beverage research
Research overview
Historical use
Yerba mate leaves are traditionally prepared as an infusion. Beverage, soluble powder, capsule and standardized extract are distinct exposures [1].
Modern research context
A systematic review found human studies with varied designs and preparations, with many at moderate/high risk of bias and certainty ranging from moderate to very low [1]. A small 12-week capsule trial and a separate 34-person standardized-extract study produced different findings; the latter found no significant overall effect on measured cardiometabolic outcomes [2,3].
Adverse effects
Available trials are small/short and do not establish long-term safety. Beverage caffeine content and preparation vary; the cited studies do not establish a universal safety profile [1-3].
Contraindications
Do not generalize extract or capsule results to traditional beverage use or vice versa. Evidence does not establish disease prevention or treatment [1-3].
Clinical and phytochemical data
Used part
Leaves, used as infusion or processed extract; products and caffeine exposure vary [1-3].
Primary active compounds
Caffeine and caffeoylquinic acids are constituents discussed in the systematic review; content varies by product [1].
Mechanism of action
The clinical evidence does not establish a single mechanism or disease-modifying effect [1-3].
Pharmacokinetics
Absorption
PK varies with infusion/extract composition; no general human PK profile is established by these sources [1-3].
Distribution
Not characterized as a general plant-product profile.
Metabolism
Not characterized as a general plant-product profile.
Excretion
Not characterized as a general plant-product profile.
Safety and interactions
Drug interactions
No comprehensive species-specific clinical interaction profile established in the cited studies.
Toxicity
Long-term safety and risk across preparation methods are not resolved by small clinical trials [1-3].
Special precautions
Pregnancy
Medicinal-dose safety in pregnancy is not established by these sources.
Lactation
Medicinal-dose safety in lactation is not established by these sources.
Hepatic impairment
No impairment-specific clinical data identified.
Renal impairment
No impairment-specific clinical data identified.
Sources and references
- [1] Manuela F. B. José et al. Physiological effects of yerba maté (Ilex paraguariensis): a systematic review. Nutrition Reviews. 2023;81(9):1163–1179. PMID: 36647770. DOI: 10.1093/nutrit/nuac109.
- [2] Sun-Young Kim et al. Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial. BMC Complementary and Alternative Medicine. 2015;15:338. PMID: 26408319. DOI: 10.1186/s12906-015-0859-1.
- [3] Karimi S. Gebara et al. A Randomized Crossover Intervention Study on the Effect a Standardized Maté Extract (Ilex paraguariensis A. St.-Hil.) in Men Predisposed to Cardiovascular Risk. Nutrients. 2021;13(1):14. PMID: 33374524. DOI: 10.3390/nu13010014.